arrow
L

Li Su

University of Cambridge
H指数:43
被引数:7,136

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Immune Profiling in Early Cognitive Disorders (IMPRINT) study protocol: a longitudinal cohort study exploring biomarkers of inflammation in early dementia with Lewy bodies and Alzheimer's disease, as part of the Dementias Platform UK

IMPRINT研究方案:一项纵向队列研究,旨在探索路易体痴呆和阿尔茨海默病早期炎症生物标志物,作为英国痴呆平台的一部分

2025-11-200
PRE
Ibrutinib combined with rituximab and high-dose methotrexate in newly diagnosed primary CNS diffuse large B-cell lymphoma: a pilot study with long-term follow-up

伊布替尼联合利妥昔单抗和高剂量甲氨蝶呤治疗新诊断的原发性中枢神经系统弥漫大B细胞淋巴瘤:一项长期随访的试点研究

2025-10-020
OAAI
Meta-analysis evaluating the efficacy and safety of various Bruton tyrosine kinase (BTK) inhibitors for central nervous system lymphoma: Novel covalent BTK inhibitors, except for ibrutinib, also demonstrate good efficacy in the treatment of primary central nervous system lymphoma

对各种布鲁顿酪氨酸激酶(BTK)抑制剂治疗中枢神经系统淋巴瘤的疗效和安全性进行评价的Meta分析:除ibrutinib外,新型共价BTK抑制剂在治疗原发性中枢神经系统淋巴瘤方面也显示出良好的疗效。

Cancer
IF5.1
2025-09-110
PRE